Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The problem of lindane.

J E Rasmussen

    Journal of the American Academy of Dermatology
    |November 1, 1981
    PubMed
    Summary
    This summary is machine-generated.

    1% lindane remains a safe and effective treatment for scabies and lice, with most adverse reactions stemming from misuse. Patient education on proper application is crucial for continued clinical success.

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Vascular birthmarks in children.

    Dermatology nursing·1998
    Same author

    Pediatric dermatology: advances in therapy.

    Journal of the American Academy of Dermatology·1997
    Same author

    Mass spectrometric quantification of markers for protein oxidation by tyrosyl radical, copper, and hydroxyl radical in low density lipoprotein isolated from human atherosclerotic plaques.

    The Journal of biological chemistry·1997
    Same author

    Erythema multiforme, Stevens-Johnson Syndrome, and toxic epidermal necrolysis.

    Dermatology nursing·1995
    Same author

    Trichothiodystrophy associated with photosensitivity, gonadal failure, and striking osteosclerosis.

    Journal of the American Academy of Dermatology·1993
    Same author

    Semantic analysis of medical records.

    Methods of information in medicine·1993
    Same journal

    Perioperative Management of Dermatologic Surgery Patients on Systemic Cancer Therapy.

    Journal of the American Academy of Dermatology·2026
    See all related articles

    Area of Science:

    • Dermatology
    • Pharmacology

    Background:

    • The clinical use of 1% lindane has faced controversy.
    • Alternative treatments have gained preference in recent years.

    Observation:

    • Adverse drug reactions (ADRs) associated with 1% lindane are rare.
    • Most reported ADRs are linked to significant misuse of the formulation.

    Findings:

    • 1% lindane demonstrates high efficacy and a favorable safety profile when used correctly.
    • The number of ADRs is small relative to its extensive use in the United States.

    Implications:

    • 1% lindane should remain a primary treatment option for scabies and lice.
    • Dermatologists must educate patients on proper usage to prevent misuse and manage potential concerns.
    • Patient counseling is essential to address negative perceptions and ensure compliance.